Deutsch English Français

Contact

EP1218031

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1218031

EP1218031 - PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIGEN [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 04.05.2007 Database last updated on 13.07.2024
Most recent event Tooltip	12.12.2008	Lapse of the patent in a contracting state New state(s): CY	published on 14.01.2009 [2009/03]
Applicant(s)	For all designated states Intercell AG Campus Vienna Biocenter 6 1030 Vienna / AT
	[2006/11]
Former [2002/27]	For all designated states Cistem Biotechnologies GmbH Rennweg 95 B 1030 Vienna / AT
Inventor(s)	01 / FLEITMANN, Julia-Kristina Hauptstrasse 89 A-2463 Gallbrunn / AT
	02 / MATTNER, Frank Krottenbachstrasse 267 A-1190 Vienna / AT
	03 / BUSCHLE, Michael 48 Gamekeeper's Road EH4 6LS Edinburgh / GB
	04 / MELLING, Jack 1 Folly Close Salisbury Wiltshire SP2 8BU / GB
	[2006/15]
Former [2002/31]	01 / FLEITMANN, Julia-Kristina Hauptstrasse 89 A-2463 Gallbrunn / AT
	02 / MATTNER, Frank Krottenbachstrasse 267 A-1190 Vienna / AT
	03 / BUSCHLE, Michael Goethestr. 2/2/9 A-2380 Perchtoldsdorf / AT
	04 / MELLING, Jack 1 Folly Close Salisbury Wiltshire SP2 8BU / GB
Former [2002/27]	01 / FLEITMANN, Julia-Kristina Hauptstrasse 89 A-2463 Gallbrunn / AT
	02 / MATTNER, Frank Krottenbachstrasse 267 A-1190 Vienna / AT
	03 / BUSCHLE, Michael Hyrtlstrasse 35/1/1 A-2345 Brunn am Gebirge / AT
	04 / MELLING, Jack 1 Folly Close Salisbury Wiltshire SP2 8BU / GB
Representative(s)	Alge, Daniel, et al SONN Patentanwälte OG Riemergasse 14 1010 Wien / AT
	[N/P]
Former [2002/27]	Alge, Daniel, Mag. Dr. rer.nat., et al Patentanwälte Sonn, Pawloy, Weinzinger & Köhler-Pavlik Riemergasse 14 1010 Wien / AT
Application number, filing date	00969387.0	02.10.2000
	[2002/27]
	WO2000EP09657
Priority number, date	AT19990001680	01.10.1999 Original published format: AT 168099
	[2002/27]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0124822
	Date:	12.04.2001
	Language:	EN
	[2001/15]
	Type:	A2 Application without search report
	No.:	EP1218031
	Date:	03.07.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.04.2001 takes the place of the publication of the European patent application.
	[2002/27]
	Type:	B1 Patent specification
	No.:	EP1218031
	Date:	28.06.2006
	Language:	EN
	[2006/26]
Search report(s)	International search report - published on:	EP	20.12.2001
Classification	IPC:	A61K39/39, A61P31/00, A61P35/00, A61P37/00, A61K39/29	[2002/27]
	CPC:	C07K14/005 (EP,US); A61K39/12 (EP,US); A61K39/29 (EP,US); A61K39/39 (EP,US); A61P31/00 (EP); A61P31/12 (EP); (+) A61P31/14 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P37/04 (EP); A61K2039/55511 (EP,US); A61K2039/55516 (EP,US); A61K2039/55522 (EP,US); A61K2039/55555 (EP,US); A61K2039/55583 (EP,US); C12N2710/16234 (EP,US); C12N2740/16034 (EP,US); C12N2770/24222 (EP,US); C12N2770/24234 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/27]
Title	German:	ANTIGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNG	[2002/27]
	English:	PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIGEN	[2002/27]
	French:	COMPOSITION PHARMACEUTIQUE COMPRENANT UN ANTIGENE	[2002/27]
Entry into regional phase	05.04.2002	National basic fee paid
	05.04.2002	Designation fee(s) paid
	05.04.2002	Examination fee paid
Examination procedure	26.04.2001	Request for preliminary examination filed International Preliminary Examining Authority: EP
	05.04.2002	Amendment by applicant (claims and/or description)
	05.04.2002	Examination requested [2002/27]
	15.06.2005	Communication of intention to grant the patent
	01.12.2005	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
	12.01.2006	Fee for grant paid
	12.01.2006	Fee for publishing/printing paid
	12.01.2006	Request for decision received: Application is deemed to be withdrawn
	18.04.2006	Result of request for decision (Application is deemed to be withdrawn): Request accepted
Divisional application(s)	EP06101092.2 / EP1745798
	EP10179382.6 / EP2269640
	EP10179386.7 / EP2269641
	EP10179390.9 / EP2269642
	EP10179393.3 / EP2269643
Opposition(s)	29.03.2007	No opposition filed within time limit [2007/23]
Request for further processing for:
Fees paid	Renewal fee
	12.10.2002	Renewal fee patent year 03
	06.10.2003	Renewal fee patent year 04
	11.10.2004	Renewal fee patent year 05
	08.10.2005	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	CY	28.06.2006
	FI	28.06.2006
	IT	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	DK	28.09.2006
	SE	28.09.2006
	GR	29.09.2006
	IE	02.10.2006
	LU	02.10.2006
	ES	09.10.2006
	MC	31.10.2006
	PT	28.11.2006
	[2009/03]
Former [2008/36]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	IT	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	DK	28.09.2006
	SE	28.09.2006
	GR	29.09.2006
	IE	02.10.2006
	LU	02.10.2006
	ES	09.10.2006
	MC	31.10.2006
	PT	28.11.2006
Former [2008/19]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	IT	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	DK	28.09.2006
	SE	28.09.2006
	GR	29.09.2006
	IE	02.10.2006
	ES	09.10.2006
	MC	31.10.2006
	PT	28.11.2006
Former [2007/48]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	IT	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	DK	28.09.2006
	SE	28.09.2006
	IE	02.10.2006
	ES	09.10.2006
	MC	31.10.2006
	PT	28.11.2006
Former [2007/37]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	IT	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	DK	28.09.2006
	SE	28.09.2006
	ES	09.10.2006
	MC	31.10.2006
	PT	28.11.2006
Former [2007/35]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	IT	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	DK	28.09.2006
	SE	28.09.2006
	ES	09.10.2006
	PT	28.11.2006
Former [2007/22]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	DK	28.09.2006
	SE	28.09.2006
	ES	09.10.2006
	PT	28.11.2006
Former [2007/19]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	LI	28.06.2006
	NL	28.06.2006
	SE	28.09.2006
	ES	09.10.2006
	PT	28.11.2006
Former [2007/13]	AT	28.06.2006
	BE	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	LI	28.06.2006
	SE	28.09.2006
	ES	09.10.2006
	PT	28.11.2006
Former [2007/12]	AT	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	LI	28.06.2006
	SE	28.09.2006
	ES	09.10.2006
	PT	28.11.2006
Former [2007/08]	AT	28.06.2006
	CH	28.06.2006
	FI	28.06.2006
	LI	28.06.2006
	SE	28.09.2006
Former [2006/52]	AT	28.06.2006
	FI	28.06.2006
	SE	28.09.2006
Former [2006/51]	FI	28.06.2006
	SE	28.09.2006
Former [2006/48]	SE	28.09.2006
Cited in	International search	[YD]WO9104052 (PEPTIDE TECHNOLOGY LTD [AU]) [YD] 1-15 * abstract * * page 1, line 22 - page 2, line 5 * * page 5, line 11 - line 17 * * page 7, line 1 - line 23 * * page 10, line 7 - line 22 * * claims 1-3 *;
		[Y]WO9116921 (HEALTH LAB SERVICE BOARD [GB]) [Y] 1-15 * abstract * * page 3, paragraph 6 * * page 5, paragraph 3 - paragraph 5 * * page 7, paragraph 2 - paragraph 3 * * claims 1-3,8-11 *;
		[A]US5562910 (DAYNES RAYMOND A [US], et al) [A] 1,2,8-11,15 * abstract * * column 2, line 65 - column 3, line 6 * * column 7, line 44 - line 51 * * column 8, line 46 - line 59 *;
		[XD]WO9730721 (BOEHRINGER INGELHEIM INT [DE], et al) [XD] 1-6 * abstract * * page 7, paragraph L - page 8, paragraph 2 * * page 9, paragraph 4 * * page 19, paragraph 4 - page 20, paragraph 1 * * claims 1,6,7,18,20-22 *;
		[PX]WO0011186 (US HEALTH [US], et al) [PX] 12-15* page 16, line 25 - page 20, line 10 *;
		[YD] - STEPHENSON J R ET AL, "ADJUVANT EFFECT OF HUMAN GROWTH HORMONE WITH AN INACTIVATED FLAVIVIRUS VACCINE", JOURNAL OF INFECTIOUS DISEASES,US,CHICAGO, IL, (199102), vol. 164, ISSN 0022-1899, pages 188 - 191, XP000882691 [YD] 1-15 * the whole document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p